Follow Newser on Twitter   Friend Newser on Facebook
Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Popular Cancer Drug Is Iffy and Expensive

Widely prescribed Avastin doesn't prolong life, studies say

By Harry Kimball,  Newser Staff

Posted Jul 6, 2008 10:48 AM CDT

(Newser) – Avastin is one of the most widely prescribed cancer drugs in the world, but it might not work, the New York Times reports. The drug, made by Genentech, brings in about $2.3 billion a year in the US alone, but recent trials have shown...   Read full story »

COMMENTS
You need to Log in to Newser to comment. Don't have an account yet? Sign up now!
There are no comments
A snapshot of the day's best news stories.
 

More Newser Stories

Shedding Light on 'Hidden' Patients: Women With Lung Cancer

FDA Clears Avastin for Breast Cancer

FDA Drops Approval of Avastin for Breast Cancer

FDA Panel: Don't Use Avastin for Breast Cancer

New Breast Cancer Drug Hails From Briny Deep


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   Geek Sugar   |   Business Insider   |   HuffPost Entertainment